E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/15/2010 in the Prospect News Distressed Debt Daily.

Quigley net loss shrinks to $509,970 in November; sales stay $50,001

By Caroline Salls

Pittsburgh, Dec. 15 - Quigley Co. Inc. reported a $509,970 net loss for November on $50,001 of revenues, according to its monthly operating report filed Dec. 15 with the U.S. Bankruptcy Court for the Southern District of New York.

In comparison, the company posted a $550,065 net loss for October, also on $50,001 of revenues.

Cash and cash equivalents were $97,531 at Nov. 30, up from $70,566 at the end of October.

Quigley, a unit of New York-based Pfizer Inc., filed for bankruptcy on Sept. 3, 2004. Its Chapter 11 case number is 04-15739.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.